titanium dioxide has been researched along with imatinib mesylate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Feng, YQ; Li, X; Liu, J; Lü, S; Luo, Q; Wang, F; Wu, J; Xiong, S | 1 |
Do, B; Karoui, M; Levi, Y; Sadou Yayé, H; Secrétan, PH; Solgadi, A; Tortolano, L; Yagoubi, N | 1 |
Choi, HG; Gautam, M; Gupta, B; Jeong, JH; Kim, JO; Ku, SK; Maharjan, S; Poudel, K; Soe, ZC; Yong, CS | 1 |
Bhullar, S; Goyal, N; Gupta, S | 1 |
4 other study(ies) available for titanium dioxide and imatinib mesylate
Article | Year |
---|---|
Inhibitor screening of protein kinases using MALDI-TOF MS combined with separation and enrichment of phosphopeptides by TiO2 nanoparticle deposited capillary column.
Topics: Antineoplastic Agents; Benzamides; Chronic Disease; Drug Screening Assays, Antitumor; Humans; Imatinib Mesylate; Leukemia, Myeloid; Nanoparticles; Phosphopeptides; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Titanium | 2010 |
Imatinib: Major photocatalytic degradation pathways in aqueous media and the relative toxicity of its transformation products.
Topics: Adsorption; Aliivibrio fischeri; Aquatic Organisms; Biodegradation, Environmental; Catalysis; Computer Simulation; Endocrine Disruptors; Imatinib Mesylate; Molecular Structure; Mutagens; Photolysis; Quantitative Structure-Activity Relationship; Titanium; Water Pollutants, Chemical | 2019 |
Stealth Polymer-Coated Graphene Oxide Decorated Mesoporous Titania Nanoplatforms for In Vivo Chemo-Photodynamic Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; HCT116 Cells; HT29 Cells; Humans; Imatinib Mesylate; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photochemotherapy; Reactive Oxygen Species; Silicon Dioxide; Titanium | 2020 |
In-vitro pH-responsive release of imatinib from iron-supplement coated anatase TiO
Topics: Humans; Hydrogen-Ion Concentration; Imatinib Mesylate; Iron; Metal Nanoparticles; Nanoparticles; Titanium | 2022 |